CSPC Innovation Stock Hits Day Low of CNY 47.60 Amid Price Pressure

CSPC Innovation Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.37% to touch an intraday low of CNY 47.60. This performance contrasts sharply with the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, CSPC has shown a significant rebound, gaining 20.19%, but its one-year performance remains concerning, with a decline of 2.2%, while the broader market has increased by 3.56%. Year-to-date, the stock has performed well, up 35.85%, yet it has faced challenges over the longer term, with a staggering 315.96% increase over three years, indicating volatility in its performance metrics. Financial indicators reveal a complex picture for CSPC. The company has reported negative results for the last ten consecutive quarters, with a return on capital employed (ROCE) at -9.81% and a net profit of CNY -95.43 million, reflecting a significant drop of 47.33%. The stock's high price-to-book ratio of 24.22 and a debt-equity ratio of -0.34 further highlight its financial positioning within the FMCG industry.